						<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Hengrui, Kailera phase 2 obesity pill results could pressure Eli Lilly&#8217;s orforglipron	</title>
	<atom:link href="https://up2info.com/corporate-news/hengrui-kailera-phase-2-obesity-pill-results-could-pressure-eli-lilly-orforglipron/feed/" rel="self" type="application/rss+xml" />
	<link>https://up2info.com/corporate-news/hengrui-kailera-phase-2-obesity-pill-results-could-pressure-eli-lilly-orforglipron/</link>
	<description>News / Analytics / Reviews</description>
	<lastBuildDate>Tue, 10 Feb 2026 20:17:20 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
